BioNTech SE (BNTX)
 NASDAQ: BNTX · Real-Time Price · USD
 104.67
 +1.32 (1.28%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
BioNTech SE Employees
BioNTech SE had 6,772 employees as of December 31, 2024. The number of employees increased by 639 or 10.42% compared to the previous year.
Employees 
 6,772
Change (1Y) 
 639
Growth (1Y) 
 10.42%
Revenue / Employee 
 $499,171
Profits / Employee 
 -$59,795
Market Cap 
25.16B
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 6,772 | 639 | 10.42% | 
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% | 
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% | 
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% | 
| Dec 31, 2020 | 1,941 | 631 | 48.17% | 
| Dec 31, 2019 | 1,310 | - | - | 
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
BNTX News
- 2 days ago - BioNTech to Host Innovation Series R&D Day on November 11, 2025 - GlobeNewsWire
- 3 days ago - BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025 - GlobeNewsWire
- 9 days ago - BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V. - GlobeNewsWire
- 12 days ago - Moderna Vs BioNTech: Who's Winning The Post-COVID Race - Seeking Alpha
- 4 weeks ago - BioNTech SE, InstaDeep Ltd - Special Call - Seeking Alpha
- 5 weeks ago - BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025 - GlobeNewsWire
- 6 weeks ago - COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says - Market Watch
- 7 weeks ago - BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy - Benzinga